Annual Shareholders Equity
$10.98 M
-$10.06 M-47.81%
December 31, 2023
Summary
- As of February 7, 2025, IKT annual stockholders equity is $10.98 million, with the most recent change of -$10.06 million (-47.81%) on December 31, 2023.
- During the last 3 years, IKT annual shareholders equity has risen by +$1.19 million (+12.20%).
- IKT annual shareholders equity is now -71.42% below its all-time high of $38.42 million, reached on December 31, 2021.
Performance
IKT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$530.60 K
-$5.63 M-110.41%
September 30, 2024
Summary
- As of February 7, 2025, IKT quarterly stockholders equity is -$530.60 thousand, with the most recent change of -$5.63 million (-110.41%) on September 30, 2024.
- Over the past year, IKT quarterly shareholders equity has dropped by -$5.63 million (-110.41%).
- IKT quarterly shareholders equity is now -101.13% below its all-time high of $47.05 million, reached on June 30, 2021.
Performance
IKT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
IKT Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -47.8% | -110.4% |
3 y3 years | +12.2% | -102.1% |
5 y5 years | +1511.0% | -102.1% |
IKT Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -71.4% | at low | -101.4% | at low |
5 y | 5-year | -71.4% | +344.5% | -101.1% | +89.7% |
alltime | all time | -71.4% | +344.5% | -101.1% | +89.7% |
Inhibikase Therapeutics Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$530.60 K(-110.4%) |
Jun 2024 | - | $5.10 M(-24.8%) |
Mar 2024 | - | $6.78 M(-38.3%) |
Dec 2023 | $10.98 M(-47.8%) | $10.98 M(-26.9%) |
Sep 2023 | - | $15.02 M(-22.8%) |
Jun 2023 | - | $19.46 M(-23.1%) |
Mar 2023 | - | $25.32 M(+20.4%) |
Dec 2022 | $21.04 M | $21.04 M(-16.3%) |
Sep 2022 | - | $25.14 M(-14.8%) |
Jun 2022 | - | $29.50 M(-13.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $34.01 M(-11.5%) |
Dec 2021 | $38.42 M(+292.6%) | $38.42 M(-11.0%) |
Sep 2021 | - | $43.16 M(-8.3%) |
Jun 2021 | - | $47.05 M(+485.5%) |
Mar 2021 | - | $8.04 M(-17.9%) |
Dec 2020 | $9.78 M(-317.9%) | $9.78 M(-290.9%) |
Sep 2020 | - | -$5.13 M(+6.1%) |
Jun 2020 | - | -$4.83 M(+2.7%) |
Mar 2020 | - | -$4.70 M(+4.7%) |
Dec 2019 | -$4.49 M(+477.1%) | -$4.49 M |
Dec 2018 | -$778.00 K | - |
FAQ
- What is Inhibikase Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics annual shareholders equity year-on-year change?
- What is Inhibikase Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics quarterly shareholders equity year-on-year change?
What is Inhibikase Therapeutics annual stockholders equity?
The current annual shareholders equity of IKT is $10.98 M
What is the all time high annual shareholders equity for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual stockholders equity is $38.42 M
What is Inhibikase Therapeutics annual shareholders equity year-on-year change?
Over the past year, IKT annual stockholders equity has changed by -$10.06 M (-47.81%)
What is Inhibikase Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of IKT is -$530.60 K
What is the all time high quarterly shareholders equity for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly stockholders equity is $47.05 M
What is Inhibikase Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, IKT quarterly stockholders equity has changed by -$5.63 M (-110.41%)